76 phenotypes from 13 alleles in 16 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Cd19tm1(cre)Cgn/Cd19+ Kmt2atm1.1Erns/Kmt2atm1.1Erns involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL	normal immune system phenotype	J:147265
Kmt2atm1.1Brad/Kmt2atm1.1Brad involves: 129S4/SvJae * C57BL/6	abnormal hematopoietic stem cell morphology	J:149811
	abnormal liver development	J:149811
	decreased common myeloid progenitor cell number	J:149811
	decreased hematopoietic stem cell number	J:149811
	lethality throughout fetal growth and development, complete penetrance	J:149811
Kmt2atm1.1Erns/Kmt2atm1.1Erns involves: 129S2/SvPas * C57BL/6 * SJL	abnormal definitive hematopoiesis	J:147265
	decreased common myeloid progenitor cell number	J:147265
	decreased erythroid progenitor cell number	J:147265
Kmt2atm1.1Erns/Kmt2atm1.1Erns Lyz2tm1(cre)Ifo/Lyz2+ involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL	normal immune system phenotype	J:147265
Kmt2atm1.1Erns/Kmt2atm1.1Erns Tg(GFAP-cre)25Mes/0 involves: 129S2/SvPas * FVB/N	abnormal astrocyte morphology	J:147104
	abnormal brain development	J:147104
	abnormal dentate gyrus morphology	J:147104
	abnormal neuron differentiation	J:147104
	abnormal neuronal precursor cell migration	J:147104
	abnormal postnatal subventricular zone morphology	J:147104
	ataxia	J:147104
	decreased neuronal precursor cell number	J:147104
	postnatal growth retardation	J:147104
	premature death	J:147104
	small olfactory bulb	J:147104
	thin cerebellar granule layer	J:147104
Kmt2atm1.1Erns/Kmt2atm1.1Erns Tg(Lck-cre)1Cwi/0 involves: 129S2/SvPas * C57BL/6 * SJL	normal immune system phenotype	J:147265
Kmt2atm1.1Erns/Kmt2atm1.1Erns Tg(Mx1-cre)1Cgn/0 involves: 129S2/SvPas * C57BL/6 * CBA * SJL	abnormal common lymphocyte progenitor cell morphology	J:147265
	abnormal definitive hematopoiesis	J:147265
	abnormal hematopoietic stem cell morphology	J:147265
	decreased bone marrow cell number	J:147265
	decreased common myeloid progenitor cell number	J:147265
	decreased erythroid progenitor cell number	J:147265
	decreased hematopoietic stem cell number	J:147265
	premature death	J:147265
Kmt2atm1.1Jjdh/Kmt2atm1.1Jjdh B6.129X1-Kmt2atm1.1Jjdh	abnormal arcus anterior morphology	J:201612
	decreased body size	J:201612
	glossopharyngeal nerve hypoplasia	J:201612
	sternebra fusion	J:201612
Kmt2atm1.1Jjdh/Kmt2atm1.1Jjdh involves: 129X1/SvJ	decreased fibroblast proliferation	J:112159
Kmt2atm1.1Mlc/Kmt2atm1.1Mlc involves: 129P2/OlaHsd * C57BL/6	abnormal blood cell morphology/development	J:183048
	abnormal hematopoietic stem cell physiology	J:183048
	decreased common myeloid progenitor cell number	J:183048
	decreased hematopoietic stem cell number	J:183048
	early cellular replicative senescence	J:183048
	embryonic lethality during organogenesis, complete penetrance	J:183048
	hemorrhage	J:183048
	hunched posture	J:183048
	liver hypoplasia	J:183048
	skin edema	J:183048
Kmt2atm1.2Erns/Kmt2atm1.2Erns involves: 129S2/SvPas * C57BL/6 * FVB/N	embryonic lethality during organogenesis, complete penetrance	J:147265
Kmt2atm1Brad/Kmt2atm1Brad Commd10Tg(Vav1-icre)A2Kio/? involves: 129S4/SvJae * C57BL/6 * C57BL/10 * CBA/Ca	abnormal bone marrow cell physiology	J:149811
	decreased common myeloid progenitor cell number	J:149811
	decreased pre-B cell number	J:149811
Kmt2atm1Clgr/Kmt2a+ B6.129-Kmt2atm1Clgr	abnormal common myeloid progenitor cell morphology	J:115001
	abnormal myelopoiesis	J:115001
	abnormal paraxial mesoderm morphology	J:115001
	abnormal proerythroblast morphology	J:115001
	abnormal rostral-caudal axis patterning	J:115001
	decreased rib number	J:115001
	increased erythroid progenitor cell number	J:115001
	normal neoplasm	J:115001
	sacral vertebral transformation	J:115001
	thoracic vertebral transformation	J:115001
	vertebral transformation	J:115001
Kmt2atm1Clgr/Kmt2atm1Clgr B6.129-Kmt2atm1Clgr	perinatal lethality, complete penetrance	J:115001
Kmt2atm1Djab/Kmt2atm1Djab involves: 129P2/OlaHsd * BALB/c	abnormal arcus anterior morphology	J:109102
	abnormal cervical axis morphology	J:109102
	cervical vertebral transformation	J:109102
	increased sternebra number	J:109102
	rib fusion	J:109102
Kmt2atm1Saam/Kmt2a+ involves: 129S1/Sv * C57BL/6	perinatal lethality, incomplete penetrance	J:140628
Kmt2atm1Saam/Kmt2a+ Tg(Mx1-cre)1Cgn/0 involves: 129S1/Sv * C57BL/6 * CBA	increased leukemia incidence	J:140628
Kmt2atm1Sjk/Kmt2a+ involves: 129S2/SvPas * C3H * C57BL/6	abnormal sternum morphology	J:29958
	anemia	J:29958
	cervical vertebral transformation	J:29958
	decreased B cell number	J:29958
	decreased birth body size	J:29958
	decreased erythrocyte cell number	J:29958
	decreased hemoglobin content	J:29958
	decreased rib number	J:29958
	lumbar vertebral transformation	J:29958
	postnatal growth retardation	J:29958
	reduced female fertility	J:29958
	thoracic vertebral transformation	J:29958
	thrombocytopenia	J:29958
	vertebral transformation	J:29958
Kmt2atm1Sjk/Kmt2atm1.2Erns involves: 129S2/SvPas * C57BL/6 * FVB/N	embryonic lethality during organogenesis, complete penetrance	J:147265
Kmt2atm1Sjk/Kmt2atm1Sjk involves: 129S2/SvPas * C3H * C57BL/6	embryonic lethality, complete penetrance	J:29958, J:147265
Kmt2atm1Sjk/Kmt2atm1Sjk involves: 129S2/SvPas * CD-1	abnormal myoblast differentiation	J:201612
	glossopharyngeal nerve hypoplasia	J:201612
Kmt2atm1Vss/Kmt2a+ involves: 129P2/OlaHsd * C57BL/6	abnormal cervical atlas morphology	J:71498
	abnormal cervical axis morphology	J:71498
	abnormal cervical vertebrae morphology	J:71498
	abnormal cranial ganglia morphology	J:71498
	abnormal dorsal root ganglion morphology	J:71498
	abnormal rib development	J:71498
	abnormal vertebral arch morphology	J:71498
	cervical vertebral fusion	J:71498
	lumbar vertebral transformation	J:71498
	thoracic vertebral transformation	J:71498
	vertebral transformation	J:71498
Kmt2atm1Vss/Kmt2atm1Vss involves: 129P2/OlaHsd * C57BL/6	embryonic lethality before implantation, complete penetrance	J:71498
Kmt2atm2.1Mlc/Kmt2atm2.1Mlc involves: 129P2/OlaHsd * C57BL/6	abnormal hematopoietic system morphology/development	J:207555
	decreased hematopoietic stem cell number	J:207555
	embryonic lethality, complete penetrance	J:207555
	hemorrhage	J:207555
	skin edema	J:207555
Kmt2atm3Mlc/Kmt2atm3Mlc involves: 129P2/OlaHsd * C57BL/6	no abnormal phenotype detected	J:207555